Class III · Low riskTerminated Initiated Oct 11, 2019 (7 years ago)
Levetiracetam Injection
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached.
What was recalled
Levetiracetam Injection, 500 mg/5mL, 10 single-use 5 mL vials, Rx only, Manufactured by: Agile Specialties Private Limited Pilot No. 14, Sipcot II, Hosur-635 109 Tamil Nadu, India, Manufactured for: X-Gen Pharmaceuticals, Inc. Big Flats, NY 14814, NDC 39822-4000-1
Recalling firm
X-Gen Pharmaceuticals Inc.
NDC code
39822-4000-1
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0519-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
Dr. Reddy's Laboratories, Inc.NDC 43598-636-52D-0365-2025
Reason Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam
McKesson Corporation dba McKesson Drug CompanyNDC 63739-795-10D-0630-2021